US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 16.840
  • -0.080-0.47%
Close Jan 10 16:00 ET
  • 16.840
  • 0.0000.00%
Post 16:01 ET
427.99MMarket Cap-0.36P/E (TTM)

Cartesian Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jan 10, 2025

Based on 8 analysts giving stock ratings to Cartesian Therapeutics in the past 3 months

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

Updated: Jan 10, 2025

The average Cartesian Therapeutics stock price target is 37.80 with a max estimate of 45.00 and a min estimate of 22.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 10, 2025

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

Updated: Jan 10, 2025